A laboratory can report strong testing volume and still face a cash-flow problem. The gap often sits in the time between a claim leaving the billing system and payment reaching the bank. To track lab accounts receivable effectively, leaders need more than an aging report. They need a disciplined view of where balances are stalled, why they are stalled, and which actions will produce recoverable revenue.
For independent toxicology and diagnostic laboratories, that visibility is especially important. Payer policies change, medical necessity edits can be narrow, documentation requirements vary, and a single credentialing issue can affect a meaningful share of claims. A practical accounts receivable process turns those variables into clear priorities instead of a growing list of unresolved balances.
Start with an AR view built for laboratory reimbursement
A standard aging report is necessary, but it is not sufficient. It shows the amount owed by aging bucket, typically 0-30, 31-60, 61-90, 91-120, and over 120 days. It does not automatically show whether the balances are collectible, who owns the next step, or whether the issue is internal, payer-related, or patient-related.
Laboratory revenue cycle leaders should segment AR in ways that support decisions. At a minimum, review balances by payer, rendering or billing provider, ordering source where appropriate, location, service line, denial reason, and claim status. For toxicology laboratories, it can also be useful to separate high-complexity testing from routine services when reimbursement rules and authorization requirements differ.
This level of detail matters because a $50,000 balance over 90 days is not one problem. It may include claims awaiting medical records, denials tied to missing prior authorization, underpayments from a contract configuration error, and claims that were never accepted due to eligibility or demographic issues. Each requires a different workflow and a different owner.
Measure the indicators that reveal risk early
Days in AR is a useful high-level measure, but it should not be the only metric used to evaluate performance. A low overall days-in-AR figure can conceal a troubling concentration of older balances with one payer. Likewise, a temporary improvement can result from writing off difficult accounts rather than resolving the causes behind them.
A stronger dashboard combines a few related measures. Monitor total AR, aging by payer, the percentage of AR over 90 days, denial volume and denial dollars, clean claim rate, first-pass payment rate, and net collection rate. Track unresolved claims approaching payer filing limits as a separate category. Those claims deserve immediate attention because the opportunity to appeal or correct them may be closing.
For many independent labs, the most actionable metric is the percentage of AR over 90 days by payer. This identifies whether follow-up is happening soon enough and whether specific payer relationships require a deeper operational response. If one payer consistently represents a disproportionate share of older AR, the issue may involve enrollment, contract setup, recurring edits, or an escalation process that is not working.
Set benchmarks carefully
There is no single ideal benchmark for every lab. A laboratory with a high percentage of governmental claims, complex toxicology panels, or a new payer mix may experience different payment patterns than a lab focused on straightforward commercial testing. The goal is not to chase a generic industry number. The goal is to establish a reliable baseline, identify unfavorable movement quickly, and improve performance without creating inappropriate write-offs or compliance risk.
Prioritize AR by recoverability, not just age
Old balances deserve attention, but age alone should not determine work priority. A recent high-dollar denial with a short appeal deadline may be more urgent than a low-dollar claim that is 110 days old and has already received multiple documented follow-ups.
An effective work queue weighs several factors: balance amount, payer timely filing and appeal deadlines, denial category, claim status, likelihood of recovery, and the availability of required documentation. Claims that can be corrected and resubmitted quickly should move fast. Claims needing clinical records, ordering-provider documentation, or formal appeals need clear ownership and due dates.
A practical approach is to separate AR into three working groups. First, resolve claims that are clean but unpaid, such as those pending beyond the payer’s normal processing window. Second, correct and resubmit denials that have clear, fixable causes. Third, escalate complex or high-value claims that require payer contact, records, reconsideration, or contract review.
This prevents staff from spending disproportionate time on claims with limited recovery potential while time-sensitive, collectible claims age unnecessarily.
Build denial intelligence into the follow-up process
Accounts receivable follow-up should not operate separately from denial management. If staff repeatedly work the same denial without identifying its root cause, the lab will continue adding new balances to the queue.
Review denial trends monthly and look for patterns in the adjustment codes, payers, test combinations, ordering sources, and billing entities involved. Common laboratory issues include medical necessity denials, missing or invalid diagnosis coding, authorization requirements, duplicate claim edits, eligibility conflicts, and provider enrollment mismatches. Underpayments should be reviewed separately, particularly when allowed amounts appear inconsistent with contracted reimbursement.
The right response depends on the finding. A documentation-related denial may require a better records request process. Repeated eligibility denials may point to insufficient front-end verification. A payer-specific medical necessity edit may call for billing rule updates and education for ordering partners. Enrollment denials may require coordinated credentialing support rather than more claim follow-up.
The key is to close the loop. Every significant denial trend should have an assigned corrective action, an accountable owner, and a date for measuring whether the change reduced future denials.
Create a consistent cadence for AR follow-up
Laboratory AR improves when follow-up is timely and standardized. Claims should not wait until they cross 60 or 90 days before anyone checks their status. Establish payer-specific follow-up intervals based on normal adjudication timing, and document each action in the billing system.
A concise note should show the date of contact, payer representative or reference number, current claim status, required next step, and the date for the next follow-up. This documentation protects continuity when staff responsibilities change and gives management a clear record of payer activity.
Weekly work should focus on exceptions, recent denials, and claims approaching key filing limits. Monthly reviews should evaluate aging movement, payer trends, staff productivity, and recurring root causes. Quarterly reviews are the right time to examine broader issues such as contract performance, credentialing status, technology workflow gaps, and changes in payer policy.
Keep patient balances accurate and patient-centered
Patient AR is different from payer AR. It requires clear statements, accurate insurance processing, reasonable payment options, and consistent communication. Sending a statement before insurance has fully adjudicated can damage trust and increase call volume. Waiting too long after final payer action can make patient balances harder to collect.
Confirm that contractual adjustments, deductibles, coinsurance, and secondary insurance are applied correctly before patient billing begins. When a balance is valid, use plain language that tells the patient what service was billed, what insurance paid or denied, and how to ask questions or make payment arrangements.
Patient billing performance is not only a collections issue. It reflects the quality of insurance verification, claims processing, and financial communication across the revenue cycle.
Use technology to support judgment, not replace it
Billing platforms can automate aging reports, work queues, claim-status checks, and reminders. These tools help teams work faster, especially when claim volume rises. But automation is only as effective as the rules behind it. An incorrect payer mapping, outdated fee schedule, or poorly designed work queue can scale a problem just as efficiently as it scales a solution.
Leaders should periodically audit queue logic, staff notes, adjustment use, and claim disposition codes. If reporting cannot explain why AR is rising or which actions are producing cash, the reporting structure needs refinement.
For laboratories that lack dedicated internal billing leadership, an experienced revenue cycle partner can provide the operational discipline and strategic oversight needed to connect AR follow-up with denial prevention, credentialing, and growth planning. Revenue Management Corporation approaches laboratory revenue performance as part of the broader business, not as an isolated collections task.
Make AR ownership visible
The most effective AR programs have clear accountability. Team members should know which payers, claim types, or workflows they own, while leaders should know what outcomes to expect. Productivity should be measured by more than the number of touches completed. The stronger question is whether work produced payment, a valid resolution, or a documented next step that moves the claim forward.
Review unresolved high-dollar accounts in a focused leadership meeting. Discuss barriers, deadlines, escalation needs, and root-cause findings. This creates the discipline to address difficult claims before they become write-offs and gives leadership the insight to make smarter long-term decisions.
When laboratories track AR with this level of purpose, the aging report becomes a management tool rather than a monthly warning. Better visibility supports faster resolution, stronger cash flow, and a revenue cycle that can support growth with greater confidence.
Recent Comments